Literature DB >> 19250287

Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review.

R Gil-Gouveia1, P J Goadsby.   

Abstract

Lidocaine has been used in treatment of patients with refractory headache. Personal observations of neuropsychiatric toxicity in these patients led us to review our cases and the literature systematically for lidocaine side-effects, especially neuropsychiatric symptoms. In our series of 20 patients, side-effects were observed in all, the most frequent being neuropsychiatric (75%) and cardiological (50%). When reviewing published series on intravenous lidocaine use, reports of side-effects range from 0 to 100%, with neuropsychiatric symptoms being reported in 1.8-100%. Thirty-six case reports of lidocaine-induced psychiatric symptoms were also analysed. Psychiatric symptoms of toxicity were similar in most patients, despite their differing ages, pathologies, co-therapies and lidocaine dosages. In conclusion, lidocaine neuropsychiatric toxicity has a well-recognized stereotypical clinical presentation that is probably unrecognized in headache series. As lidocaine represents an emerging alternative therapy in headache, particularly in short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing, clinicians and patients should be aware of the extent of this problem.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250287     DOI: 10.1111/j.1468-2982.2008.01800.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

1.  Stress, emotion and the heart: tako-tsubo cardiomyopathy.

Authors:  M Bilal Iqbal; James C Moon; Oliver P Guttmann; Paul Shanahan; Peter J Goadsby; Diana R Holdright
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 2.  Intravenous lidocaine and mexiletine in the management of trigeminal autonomic cephalalgias.

Authors:  Michael J Marmura
Journal:  Curr Pain Headache Rep       Date:  2010-04

Review 3.  Inpatient management of migraine.

Authors:  Michael J Marmura; Stephanie Wrobel Goldberg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

4.  Effects of Systemic Lidocaine Versus Dexmedetomidine on the Recovery Quality and Analgesia After Thyroid Cancer Surgery: A Randomized Controlled Trial.

Authors:  Teng Shu; Siqi Xu; Xia Ju; Shenghong Hu; Shengbin Wang; Li Ma
Journal:  Pain Ther       Date:  2022-10-06

5.  Ranolazine attenuates behavioral signs of neuropathic pain.

Authors:  Harry J Gould; Colleen Garrett; Renee R Donahue; Dennis Paul; Ivan Diamond; Bradley K Taylor
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

Review 6.  Update of Inpatient Treatment for Refractory Chronic Daily Headache.

Authors:  Tzu-Hsien Lai; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 7.  Efficacy of medications in adult patients with trigeminal neuralgia compared to placebo intervention: a systematic review with meta-analyses.

Authors:  Georgia M Peterson-Houle; Magda R AbdelFattah; Mariela Padilla; Reyes Enciso
Journal:  J Dent Anesth Pain Med       Date:  2021-10-01

8.  Intravenous Lidocaine and Ketamine Infusions for Headache Disorders: A Retrospective Cohort Study.

Authors:  Jason C Ray; Shuli Cheng; Kirsten Tsan; Hassan Hussain; Richard J Stark; Manjit S Matharu; Elspeth Hutton
Journal:  Front Neurol       Date:  2022-03-09       Impact factor: 4.003

9.  Lidocaine bolus may facilitate computed tomographic coronary angiography in patients with frequent premature ventricular contractions.

Authors:  Jerzy Pręgowski; Jan Jastrzębski; Cezary Kępka; Mariusz Kruk; Marcin Demkow; Lukasz Kalińczuk; Rafał Wolny; Michał Ciszewski; Ilona Michałowska; Adam Witkowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-09-16       Impact factor: 1.426

Review 10.  Multidisciplinary Tinnitus Research: Challenges and Future Directions From the Perspective of Early Stage Researchers.

Authors:  Jorge Piano Simoes; Elza Daoud; Maryam Shabbir; Sana Amanat; Kelly Assouly; Roshni Biswas; Chiara Casolani; Albi Dode; Falco Enzler; Laure Jacquemin; Mie Joergensen; Tori Kok; Nuwan Liyanage; Matheus Lourenco; Punitkumar Makani; Muntazir Mehdi; Anissa L Ramadhani; Constanze Riha; Jose Lopez Santacruz; Axel Schiller; Stefan Schoisswohl; Natalia Trpchevska; Eleni Genitsaridi
Journal:  Front Aging Neurosci       Date:  2021-06-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.